Therefore, VAV2 expression level might serve as a biomarker for predicting radiosensitivity of ESCC and perhaps some other types of cancer in view of the results we have obtained from the pan-cancer analysis. Here, VAV2 is linked to esophageal squamous cell carcinoma.